These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25796267)

  • 1. A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial).
    Bull S; Loudon M; Francis JM; Joseph J; Gerry S; Karamitsos TD; Prendergast BD; Banning AP; Neubauer S; Myerson SG
    Eur Heart J Cardiovasc Imaging; 2015 Aug; 16(8):834-41. PubMed ID: 25796267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function.
    O'Brien KD; Zhao XQ; Shavelle DM; Caulfield MT; Letterer RA; Kapadia SR; Probstfield JL; Otto CM
    J Investig Med; 2004 Apr; 52(3):185-91. PubMed ID: 15222408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot).
    Babu-Narayan SV; Uebing A; Davlouros PA; Kemp M; Davidson S; Dimopoulos K; Bayne S; Pennell DJ; Gibson DG; Flather M; Kilner PJ; Li W; Gatzoulis MA
    Int J Cardiol; 2012 Feb; 154(3):299-305. PubMed ID: 20970202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramipril and left ventricular diastolic function in stable patients with pulmonary regurgitation after repair of tetralogy of Fallot.
    Krupickova S; Li W; Cheang MH; Rigby ML; Uebing A; Davlouros P; Dimopoulos K; Di Salvo G; Fraisse A; Swan L; Alonso-Gonzalez R; Kempny A; Pennell DJ; Senior R; Gatzoulis MA; Babu-Narayan SV
    Int J Cardiol; 2018 Dec; 272():64-69. PubMed ID: 30153993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
    Lonn E; Shaikholeslami R; Yi Q; Bosch J; Sullivan B; Tanser P; Magi A; Yusuf S
    J Am Coll Cardiol; 2004 Jun; 43(12):2200-6. PubMed ID: 15193680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study.
    Dalsgaard M; Iversen K; Kjaergaard J; Grande P; Goetze JP; Clemmensen P; Hassager C
    Am Heart J; 2014 Feb; 167(2):226-34. PubMed ID: 24439984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study.
    Therrien J; Provost Y; Harrison J; Connelly M; Kaemmerer H; Webb GD
    Int J Cardiol; 2008 Sep; 129(2):187-92. PubMed ID: 18672299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure.
    MacDonald KA; Kittleson MD; Larson RF; Kass P; Klose T; Wisner ER
    J Vet Intern Med; 2006; 20(5):1093-105. PubMed ID: 17063701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril.
    MacMahon S; Sharpe N; Gamble G; Clague A; Mhurchu CN; Clark T; Hart H; Scott J; White H
    J Am Coll Cardiol; 2000 Aug; 36(2):438-43. PubMed ID: 10933355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.
    Knoll GA; Fergusson D; Chassé M; Hebert P; Wells G; Tibbles LA; Treleaven D; Holland D; White C; Muirhead N; Cantarovich M; Paquet M; Kiberd B; Gourishankar S; Shapiro J; Prasad R; Cole E; Pilmore H; Cronin V; Hogan D; Ramsay T; Gill J
    Lancet Diabetes Endocrinol; 2016 Apr; 4(4):318-26. PubMed ID: 26608067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis.
    Stewart RA; Kerr AJ; Cowan BR; Young AA; Occleshaw C; Richards AM; Edwards C; Whalley GA; Freidlander D; Williams M; Doughty RN; Zeng I; White HD;
    Am Heart J; 2008 Aug; 156(2):348-55. PubMed ID: 18657667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES).
    Kjøller-Hansen L; Steffensen R; Grande P
    J Am Coll Cardiol; 2000 Mar; 35(4):881-8. PubMed ID: 10732883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.
    Verdecchia P; Sleight P; Mancia G; Fagard R; Trimarco B; Schmieder RE; Kim JH; Jennings G; Jansky P; Chen JH; Liu L; Gao P; Probstfield J; Teo K; Yusuf S;
    Circulation; 2009 Oct; 120(14):1380-9. PubMed ID: 19770395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
    Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
    Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).
    Chockalingam A; Venkatesan S; Subramaniam T; Jagannathan V; Elangovan S; Alagesan R; Gnanavelu G; Dorairajan S; Krishna BP; Chockalingam V;
    Am Heart J; 2004 Apr; 147(4):E19. PubMed ID: 15077102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
    ; Yusuf S; Sleight P; Pogue J; Bosch J; Davies R; Dagenais G
    N Engl J Med; 2000 Jan; 342(3):145-53. PubMed ID: 10639539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term therapy with ramipril in high-risk women.
    Lonn E; Roccaforte R; Yi Q; Dagenais G; Sleight P; Bosch J; Suhan P; Micks M; Probstfield J; Bernstein V; Yusuf S;
    J Am Coll Cardiol; 2002 Aug; 40(4):693-702. PubMed ID: 12204499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with ramipril improves systolic function even in patients with mild systolic dysfunction and symptoms of heart failure after acute myocardial infarction.
    Kongstad-Rasmussen O; Blomstrand P; Broqvist M; Dahlström U; Wranne B
    Clin Cardiol; 1998 Nov; 21(11):807-11. PubMed ID: 9825192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibition with ramipril improves left ventricular function at rest and post exercise in patients with stable ischaemic heart disease and preserved left ventricular systolic function.
    Willenheimer R; Rydberg E; Oberg L; Juul-Möller S; Erhardt L
    Eur Heart J; 1999 Nov; 20(22):1647-56. PubMed ID: 10543928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril.
    Mathew J; Sleight P; Lonn E; Johnstone D; Pogue J; Yi Q; Bosch J; Sussex B; Probstfield J; Yusuf S;
    Circulation; 2001 Oct; 104(14):1615-21. PubMed ID: 11581138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.